Market Herald logo

Subscribe

Be the first with the news that moves the market

Markets on both sides of the border couldn’t extend their rally from the previous session on Thursday, however inflation appears to be cooling on the horizon. Economists are now expecting a smaller increase in interest rates come September. The industrials, tech, health care, and utilities sectors were the decliners among TSX indices.


Sponsored by
VERTEX REPORTS RECORD SECOND QUARTER 2022 RESULTS

Traders predict a 67.5 per cent chance that the U.S. Fed will hike the interest rate by 50 basis points. Data showed U.S. producer prices fell last month thanks to a drop in the cost for energy products. Japanese markets were closed for Mountain Day.

Today in the Markets

TSX 19,991.88 +105.94 TSX
TSXV 673.02 +3.30 TSXV
CSE 287.62 +3.11 TSXV
DJIA 33,336.67 +27.16 DJIA
NASDAQ 12,779.91 -74.89 NASDAQ
S&P 500 4,207.27 -2.97 S&P 500

The Canadian dollar traded for 78.36 cents US compared to 78.33 cents US on Wednesday.

US crude futures traded 2.18 per cent higher at $93.19 a barrel, while the Brent contract gained 1.90 per cent to $99.25 a barrel.

The price of gold was down US$4.63 to US$1,787.09.

In world markets, the Nikkei remained at 27,819.33, the Hang Seng was up 471.59 points to 20,082.43, the FTSE was down 14.80 points to 7,588.74, and the DAX was down 6.42 points to 13,694.51.


Get @ the Bell delivered to your email inbox every day!

Sign Up Here





DISCLAIMER: By viewing any material on or distributed by The Market Herald Publishing Ltd. and its Information Providers you agree to both the following disclaimer, and the full disclaimer that can be viewed here.

Any holdings, theories, speculation or trades appearing anywhere on The Market Herald network of websites should not be relied upon for purposes of transacting securities or other investments, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. This applies to any material regardless of source, placement, presentation or reproduction. Any Information Providers to The Market Herald or employees of The Market Herald may from time to time have positions in the stocks or other entities mentioned anywhere on The Market Herald Network of websites. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment. The Market Herald and its contributors makes no guarantee as to the validity of any information, speculation, theories or research presented herein whether pertaining to the past, present or future. The Service and The Materials are provided by The Market Herald and other Information Providers on an “as is” basis, and The Market Herald and other Information Providers expressly disclaim any and all warranties, express or implied, including, without limitation, warranties of satisfactory quality and fitness for a particular purpose, with respect to the service or any materials and products. In no event shall The Market Herald and other Information Providers be liable for any direct, indirect, incidental, punitive, or consequential damages of any kind whatsoever with respect to The Service, The Materials, and The Products.


More From The Market Herald

" No pain, no blood: BETTER Type 2 diabetes testing is coming to market

Over the past two years, reporting on the Covid-19 pandemic has dominated media airwaves.
The Market Herald Video

" BioVaxys (CSE:BIOV) expands vaccines intellectual property portfolio

BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platform.

" Huge opportunity with mispriced uranium assets

Meet Fission 3.0 Corp (TSXV:FUU/OTC:FISOF).

" Silvercorp Metals Inc. Confirms Its Golden Potential with a Reserve and Resource Update

By Dr. Ryan D. Long